Critical Care MedicinePIT RegistryNCT07070258
Pediatric Intensive Care Transport Registry
An observational study of Critical Care Medicine and Transportation of Patients, run by Philipps University Marburg at 2 sites in Germany.
Trial summary
The aim is to establish a nationwide registry for pediatric intensive care transports in Germany. The project aims to describe and analyse the need for, and current practice of, specialised transports. These data could then be used for future demand planning. Read more about this study
- Who is it for?
- Ages 27 days to 17 years
- Conditions the study is for
- Critical Care Medicine, Transportation of Patients, Pediatrics
- How many people
- 1,000 participants
- Where
- 2 sitesGermany
- Study dates
- 25 Nov 2024to 31 Dec 2029
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 27 days to 17 years
- All sexes
- No healthy volunteers
- Child
Study population: All critically ill children undergoing interhospital pediatric intensive care transport and arriving at a participating center.
Who may be able to join
- Critically ill children aged at least 27 days and a corrected gestational age of over 41 weeks AND
- Maximum age of 17 years AND
- Interhospital transport AND
- Critical care transport by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance OR
- The transport was accompanied by a specialist in intensive care or emergency medicine. OR
- The in-hospital destination of the transport is a critical care area, such as an intensive care unit, a trauma room, a resuscitation area, an operating theatre, an emergency imaging procedure or an emergency intervention.
Who cannot join
None listed.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Germany2 sites, 2 recruiting
- Recruiting
University of Dresden
Dresden, 01307
- Recruiting
Philipps University of Marburg
Marburg, 35043
About this study
The aim is to establish a nationwide registry for pediatric intensive care transports in Germany. The project aims to describe and analyse the need for, and current practice of, specialised transports. These data could then be used for future demand planning.
Read the detailed description
In contrast to critical care transport of adults or newborns, transport of pediatric critical care patients in Germany is neither regulated by law nor centrally organized. Due to their different therapeutic needs compared to newborns or adults, critically ill children may receive insufficient treatment during transport. In some regions in Germany, pediatric centers provide specialized pediatric retrieval teams, while others organize each transport individually. Currently, no valid data on pediatric critical care transports in Germany are available, nor are they recorded in a structured manner.
A nationwide registry for pediatric intensive care transports in Germany was initiated to describe and analyze the need for and current practice of these specialized transports.
- Keywords
- intensive care transport, critical care transport, pediatrics, registry
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Critically ill children undergoing interhospital pediatric intensive care transport | All critically ill children undergoing interhospital pediatric intensive care transport, aged at least 27 days and with a corrected gestational age of over 41 weeks, are eligible for inclusion. The upper age limit for enrolment is 18 years. Critical care transports are defined as transports that meet at least one of the following criteria: I) The transport was performed by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance. II) The transport was accompanied by a specialist in intensive care or emergency medicine. III) The in-hospital destination of the transport is a critical care area, such as an intensive care unit, a trauma room, a resuscitation area, an operating theatre, an emergency imaging procedure or an emergency intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Most frequent reason for pediatric intensive care transport
Measured: At enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2025
- Study start25 Nov 2024
- Primary completion31 Dec 2029 (estimated)
- Study completion31 Dec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Critical Care MedicineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Philipps University Marburg
- Sponsor type
- University, hospital or other
- Collaborators
- Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin
- Responsible party
- Principal investigator, Dr. med. Nadine Mand, Philipps University Marburg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07070258
- Sponsor's protocol ID
- REG-EK-270072024
- Acronym
- PIT Registry
- Status last verified
- Jul 2025
- First submitted
- 8 Jul 2025
- Last updated
- 20 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pediatric Intensive Care Transport Registry
- ClinicalTrials.gov ID
- NCT07070258
- Acronym / sponsor ID
- PIT Registry / REG-EK-270072024
- Keywords
- intensive care transport, critical care transport, pediatrics, registry
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Philipps University MarburgUniversity, hospital or other
- Collaborators
- Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin
- Study start
- 25 Nov 2024 (actual)
- Primary completion
- 31 Dec 2029 (estimated)
- Study completion
- 31 Dec 2029 (estimated)
- First posted
- 17 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim is to establish a nationwide registry for pediatric intensive care transports in Germany. The project aims to describe and analyse the need for, and current practice of, specialised transports. These data could then be used for future demand planning.
Detailed description
In contrast to critical care transport of adults or newborns, transport of pediatric critical care patients in Germany is neither regulated by law nor centrally organized. Due to their different therapeutic needs compared to newborns or adults, critically ill children may receive insufficient treatment during transport. In some regions in Germany, pediatric centers provide specialized pediatric retrieval teams, while others organize each transport individually. Currently, no valid data on pediatric critical care transports in Germany are available, nor are they recorded in a structured manner.
A nationwide registry for pediatric intensive care transports in Germany was initiated to describe and analyze the need for and current practice of these specialized transports.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Critically ill children undergoing interhospital pediatric intensive care transport | – | –All critically ill children undergoing interhospital pediatric intensive care transport, aged at least 27 days and with a corrected gestational age of over 41 weeks, are eligible for inclusion. The upper age limit for enrolment is 18 years. Critical care transports are defined as transports that meet at least one of the following criteria: I) The transport was performed by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance. II) The transport was accompanied by a specialist in intensive care or emergency medicine. III) The in-hospital destination of the transport is a critical care area, such as an intensive care unit, a trauma room, a resuscitation area, an operating theatre, an emergency imaging procedure or an emergency intervention. |
Who may qualify
- Ages
- 27 days to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- All critically ill children undergoing interhospital pediatric intensive care transport and arriving at a participating center.
Key inclusion criteria (6 listed)
- Critically ill children aged at least 27 days and a corrected gestational age of over 41 weeks AND
- Maximum age of 17 years AND
- Interhospital transport AND
- Critical care transport by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance OR
- The transport was accompanied by a specialist in intensive care or emergency medicine. OR
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Most frequent reason for pediatric intensive care transport
Time frame: At enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Critical Care Medicine
Not yet recruitingObservational study
The Irish Perioperative OutcomeS (IPOS) Study
Outcomes Following Major Surgery in Older Adults
Enrolling by invitationPhase 4
Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension
Vasodilatory Shock
RecruitingObservational study
CytOSorb TreatMent Of Critically Ill PatientS Registry
Septic Shock, Acute Respiratory Distress Syndrome
RecruitingPhase 2
Prevent Cardiac Surgery Associated AKI Trial
Renal Failure, Coronary Artery Disease
Not yet recruitingPhase 1
The TTM and ASM Trial
Critical Care Medicine, Emergency Medical Services
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Critical Care Medicine and Transportation of Patients, run by Philipps University Marburg at 2 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nadine Mand, Dr. med. (004964215862671, mandn@staff.uni-marburg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Most frequent reason for pediatric intensive care transport (time frame: At enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2025.